Mukand Sumi Special Steel Reports Q3FY26 Results with Total Income of ₹697.33 Crore

1 min read     Updated on 26 Feb 2026, 01:18 PM
scanx
Reviewed by
Radhika SScanX News Team
Overview

Mukand Sumi Special Steel Limited reported Q3FY26 results with total income of ₹697.33 crore and net profit of ₹31.77 crore. The company achieved significant operational milestones including land acquisition for a 0.35 MTPA Green Field Steel Plant and capacity expansion at Hospet plant. Nine-month performance showed total income of ₹1959.59 crore with net profit of ₹77.61 crore and earnings per share of ₹16.64.

33637716

*this image is generated using AI for illustrative purposes only.

Mukand Sumi Special Steel Limited announced its unaudited financial results for the quarter and nine months ended December 31, 2025, demonstrating solid operational performance across key metrics. The company's Board of Directors reviewed and approved these results at their meeting held on February 24, 2026.

Financial Performance Overview

The company delivered strong financial results for the third quarter of FY26, showing growth in key revenue metrics compared to the previous year.

Metric Q3 FY26 Q3 FY25 Nine Months FY26
Total Income from Operations ₹697.33 crore ₹668.11 crore ₹1959.59 crore
Net Profit Before Tax ₹41.12 crore ₹61.64 crore ₹102.43 crore
Net Profit After Tax ₹31.77 crore ₹44.70 crore ₹77.61 crore
Earnings Per Share ₹6.81 ₹9.59 ₹16.64
Tax Expense ₹9.35 crore ₹16.94 crore ₹24.83 crore

Operational Developments

Mukand Sumi Special Steel has made significant progress in expanding its operational capabilities and infrastructure development. The company has successfully acquired land required for constructing an Integrated Steel Plant to establish a 0.35 MTPA Green Field Steel Plant. The company has applied for environmental clearance certificate with the Ministry of Environment and Forest, Government of India for this project.

Capacity Enhancement Initiatives

The company has undertaken several capacity expansion projects to strengthen its manufacturing capabilities:

  • Annealing Facility Expansion: Additional capacity has been created by establishing EBNOR and STC furnaces at the Hospet plant
  • Production Milestone: The Rolling Mill at Hospet plant achieved its highest production level in December 2025
  • Infrastructure Development: Continued focus on modernizing and expanding existing facilities

Corporate Structure

The company maintains a paid-up equity share capital of ₹46.63 crore with a face value of ₹10 per share. Reserves excluding revaluation reserves stood at ₹2332.44 crore as per the audited balance sheet as of March 31, 2025.

Regulatory Compliance

The financial results have undergone limited review by the company's auditors for the quarter and nine months ended December 31, 2025. The company noted that these results are not being published in pursuance of any regulatory requirement and hence do not conform to any specific format of published results in this regard.

Mukand Sumi Special Steel Limited continues to focus on operational excellence and strategic expansion initiatives while maintaining strong financial fundamentals across its business segments.

Historical Stock Returns for Fortis Malar Hospitals

1 Day5 Days1 Month6 Months1 Year5 Years
-0.66%-3.14%+0.06%-20.27%-9.61%+3.45%
like18
dislike

Fortis Malar Hospitals Limited Issues Postal Ballot Notice for Director Appointments with March 27, 2026 Voting Deadline

3 min read     Updated on 25 Feb 2026, 07:53 PM
scanx
Reviewed by
Naman SScanX News Team
Overview

Fortis Malar Hospitals Limited has issued a postal ballot notice under Regulation 30 of SEBI LODR seeking shareholder approval for three key resolutions: appointment of Mr. Bidesh Chandra Paul as Director and Whole-Time Director (without remuneration), and re-appointment of Ms. Shailaja Chandra as Independent Director for a second five-year term. The e-voting period runs from February 26 to March 27, 2026, with results to be declared by March 31, 2026.

33575036

*this image is generated using AI for illustrative purposes only.

Fortis Malar Hospitals Limited has issued a comprehensive postal ballot notice to shareholders on February 25, 2026, seeking approval for critical board appointments and re-appointments under Regulation 30 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015. The company has outlined three key resolutions requiring shareholder consent through the postal ballot process.

Key Proposals for Shareholder Approval

The postal ballot encompasses three significant director-related resolutions that will shape the company's leadership structure:

Resolution: Details Type
1 Appointment of Mr. Bidesh Chandra Paul as Director Ordinary Resolution
2 Appointment of Mr. Bidesh Chandra Paul as Whole-Time Director Special Resolution
3 Re-appointment of Ms. Shailaja Chandra as Independent Director Special Resolution

Director Appointment Details

Mr. Bidesh Chandra Paul (DIN: 08596135) was initially appointed as an Additional Director effective January 18, 2026. The company now seeks formal approval for his appointment as Director and subsequently as Whole-Time Director for a three-year term beginning February 6, 2026. Notably, he will receive no remuneration from the company but will be entitled to reimbursement of legitimate business expenses as per HR policy.

Mr. Paul brings over 15 years of healthcare and operations experience, holding dual degrees from IIT Kharagpur and a Post Graduate Programme from IIM Bangalore. Since joining Fortis in August 2019, he has delivered significant strategic outcomes, including 31% revenue growth over four years at Fortis Heart Institute, Okhla.

Ms. Shailaja Chandra (DIN: 03320688) seeks re-appointment as Independent Director for a second five-year term from March 10, 2026 to March 9, 2031. Having served her first term since March 10, 2021, she brings over 20 years of health sector experience as a former Secretary in the Ministry of Health & Family Welfare and Delhi's Chief Secretary. At 82 years of age, her appointment requires special resolution approval under SEBI LODR regulations.

Voting Process and Timeline

The company has established a comprehensive voting framework with specific deadlines and procedures:

Parameter: Details
Cut-off Date Friday, February 20, 2026
E-voting Commencement Thursday, February 26, 2026 at 9:00 a.m. (IST)
Voting Deadline Friday, March 27, 2026 at 5:00 p.m. (IST)
Result Declaration On or before March 31, 2026 at 5:00 p.m. (IST)
Scrutinizer Mr. Mukesh Agarwal, M/s. Mukesh Agarwal & Co

Regulatory Compliance and E-voting Facility

The postal ballot process adheres to Section 110 of the Companies Act, 2013, and SEBI LODR Regulations. The company has partnered with KFin Technologies Limited for e-voting facilitation, ensuring shareholders can cast votes electronically. The notice emphasizes that shareholders must choose only one voting mode - either postal ballot form or e-voting - with e-voting taking precedence if both methods are used.

In compliance with Regulation 30 of SEBI LODR, the company formally notified BSE Limited on February 25, 2026, about the postal ballot notice dispatch. The notice was signed by Company Secretary Vinti Verma (ICSI Membership No. A44528), confirming adherence to corporate governance requirements.

Remuneration and Compensation Structure

The proposed appointments reflect distinct compensation approaches:

Director: Compensation Details
Mr. Bidesh Chandra Paul No remuneration; expense reimbursements only
Ms. Shailaja Chandra Rs. 7.50 lakhs sitting fees for FY 2024-25
Meeting Fee Structure Rs. 50,000 per meeting attended

The appointments address specific organizational needs, with Mr. Paul's appointment following the resignation of Mr. Chandrasekar Ramasamy as Whole-Time Director effective January 18, 2026. Ms. Chandra's re-appointment continues her valuable contribution based on performance evaluation conducted throughout her current tenure, focusing on attendance, participation quality, and governance implementation.

Historical Stock Returns for Fortis Malar Hospitals

1 Day5 Days1 Month6 Months1 Year5 Years
-0.66%-3.14%+0.06%-20.27%-9.61%+3.45%
like20
dislike

More News on Fortis Malar Hospitals

1 Year Returns:-9.61%